Immediate Impact
38 standout
Citing Papers
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
2025 Standout
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
2025 Standout
Works of Maoquan Qin being referenced
The Effectiveness of Ruxolitinib for Acute/Chronic Graft-versus-Host Disease in Children: A Retrospective Study
2021
4SCAR‐GD2‐modified T‐cell therapy in neuroblastoma with MYCN amplification: A case report with over 4‐year follow‐up data
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Maoquan Qin | 124 | 87 | 53 | 64 | 44 | 321 | |
| Tai Ju Hwang | 119 | 59 | 69 | 30 | 58 | 359 | |
| Elizabeth L. Courville | 130 | 142 | 62 | 32 | 45 | 361 | |
| Georgios Paterakis | 87 | 92 | 101 | 32 | 31 | 361 | |
| Hasan Hashem | 98 | 99 | 88 | 29 | 36 | 370 | |
| Nobuyuki Hyakuna | 145 | 45 | 76 | 63 | 33 | 355 | |
| S. Schmitz | 88 | 114 | 44 | 78 | 34 | 344 | |
| Rita Balter | 89 | 111 | 45 | 19 | 36 | 344 | |
| G Bilski-Pasquier | 131 | 66 | 48 | 37 | 62 | 325 | |
| J.G. Fuzibet | 149 | 62 | 21 | 50 | 36 | 328 | |
| Michihiko Masuda | 170 | 113 | 95 | 22 | 26 | 362 |
All Works
Login with ORCID to disown or claim papers
Loading papers...